Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4865]

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

Wake-up call for dormant cancer

Wake-up call for dormant cancer

Prostate cancer discovery opens door to more tailored treatments

Prostate cancer discovery opens door to more tailored treatments

Drug targets identified for pancreatic cancer

Drug targets identified for pancreatic cancer

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or microsatellite instability high unresectable or metastatic colorectal cancer approved in the UK

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or...

Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

For colon cancer that no longer responds to treatment, a new drug combination offers hope

For colon cancer that no longer responds to treatment, a new drug combination offers hope

Towards understanding tumors in 3D

Towards understanding tumors in 3D

New cells in connective tissue open up strategy against pancreatic cancer

New cells in connective tissue open up strategy against pancreatic cancer

University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst

University effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst

More from ecancer